CB
Crane Biosciences is developing immunotherapy techniques that train the human immune system to recognize and attack cancer cells. By enhancing immune response, the company aims to improve treatment outcomes for cancer patients.
Updated 20 months ago
Funding
$10K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NA
Funding rounds are not available yet.
Founders
Product
Features
- Okay, I understand. I will analyze the provided information, extract the key elements, and construct a startup description that adheres to the specified structure, content, and style guidelines. I will focus on clarity, conciseness, and the use of appropriate technical terminology. I will also avoid any prohibited information.